2025 International Congress Archives - Page 57 of 181

Distribution of Genomic Ancestries and Genetic Variation Among Individuals Enrolled in the PD GENEration Study

A. Dilliott, K. Ghosh Galvelis, N. Bothwick, L. Caboy, M. Caulfield, R. de Leon, M. Dini, I. Khaderi, S. Rao, A. Yake, A. Coral Zambrano, J. Solle, C. Blauwendraat, A. Singleton, J. Beck, R. Alcalay (Miami, USA)
Diverse clinical phenotypes of ATP1A3 mutations-A case series of four patients

S. Rath, V. Holla, P. Pal, N. Kamble, R. Yadav (BANGALORE, India)
Do Peripheral Inflammatory Markers Predict Impulse Control Disorders in Parkinson’s Disease? Insights from a Retrospective Study

N. Durmaz Celi̇k, M. Yildiz, S. Ozkan (Eskisehir, Turkey)
Do We Agree? Patient and Clinician Ratings of Head Tremor in Isolated Cervical Dystonia

A. Lin, R. Pamintuan, Y. Han, M. Kim, M. Luu, R. Barbano, B. Berman, C. Comella, J. Feuerstein, H. Jinnah, D. Martino, J. Perlmutter, G. Stebbins, A. Wagle-Shukla, S. Pirio Richardson, D. Peterson (La Jolla, USA)
Does 10-year STN-DBS impact the natural progression of Parkinsons Disease? A Multicenter Retrospective Controlled Observational Study

A. Gozzi, S. Convenga, L. Romito, F. Bove, F. Cavallieri, E. Scelzo, R. Cilia, R. Eleopra, V. Fraix, A. Castrioto, AR. Bentivoglio, C. Piano, I. Isaias, A. Priori, M. Sensi, D. Azzolina, P. Pellissier, S. Meoni, E. Moro (Grenoble, France)
Does COMT Play a Role in Parkinson’s Disease Susceptibility Across Diverse Ancestral Populations?

M. Martin-Bórnez, N. Shar, M. Nour, D. Murphy, I. Elsayed, M. Shri, F. Nwaokorie, A. Olusanya, N. Kuznetsov, S. Bandres-Ciga, A. Noyce, H. Iwaki, L. Jones, P. Gómez-Garre, P. Mir, MT. Periñan (Sevilla, Spain)
Does the cerebellum compensate to enable motor learning in Parkinson’s Disease?

PC. Iyer, BE. Fisher (Los Angeles, USA)
Dopa Decarboxylase as a Biomarker for Parkinsons Disease and Its Relationship to L-Dopa Influence and Sample Size Estimates

J. Chung, A. Rhodes, P. Artoni, Y. Matsuki, K. Otake, J. Padmanabhan, D. Prilutsky (Cambridge, USA)
Dopa-Responsive Parkinsonism Secondary to Tauopathy: Clinical, Pathological, and Genetic Study

S. Giri Ravindran, B. Daud Shah, E. Noyes, V. Zherebitskiy, A. Rajput, M. Farrer, A. Rajput (Saskatoon, Canada)
Dopamine replacement therapy modulates dopa decarboxylase, prolactin and AOC3 levels in Parkinson’s disease

L. van Hillegondsberg, S. Ahmad, M. Fletcher, A. Taylor, A. Thompson, M. Hu (Oxford, United Kingdom)